Skip to content
Open access

Inverted logic of ecDNA localization converts nuclear periphery into oncogenic transcription hubs in cancer

Sep 2026 · bioRxiv · 0 citations
Medicine Biology

TL;DR

It is shown that ecDNAs, in contrast to chromosomal DNA, preferentially localize to the nuclear periphery yet resist peripheral gene silencing, and single-molecule multi-omic sequencing and imaging-based CRISPR screening demonstrate enhanced ecDNA hub formation, H3K27ac and H3K9me3 bivalency, late DNA replication, long-range CpG hypomethylation, and increased transcriptional output when ecDNAs localize

Abstract

Extrachromosomal DNA (ecDNA) is a major driver of cancer pathogenesis, however, its spatial organization in the nucleus is not currently understood. Here we show that ecDNAs, in contrast to chromosomal DNA, preferentially localize to the nuclear periphery yet resist peripheral gene silencing. Single-molecule multi-omic sequencing and imaging-based CRISPR screening demonstrate enhanced ecDNA hub formation, H3K27ac and H3K9me3 bivalency, late DNA replication, long-range CpG hypomethylation, and increased transcriptional output when ecDNAs localize to the nuclear periphery. EcDNA anchors to the nuclear lamina through H3K9me3-dependent interactions with the Lamin B Receptor (LBR), which if interrupted, results in inward migration of ecDNA particles, reduced ecDNA congregation, and decreased transcription of ecDNA-encoded genes. These results reveal inherent advantages of the spatial organization of ecDNA that are not available to chromosomal DNA, enhancing ecDNA congregation and amplifying oncogenic transcriptional output, by localizing to the nuclear periphery of cancer cells.

Read PDF

Similar papers

Review Open access Sep 2026

Extrachromosomal DNA as a platform for epigenetic reprogramming in cancer

Extrachromosomal DNA (ecDNA) has emerged as a major contributor to cancer aggressiveness, yet its role extends far beyond its classical definition as a vehicle for oncogene amplification. Recent studies indicate that ecDNA functions as a dynamic regulatory platform that reshapes chromatin accessibility, enhancer activi...

Bi-Xia Liu, Lu-Yuan Zhou, Shu-Zhen Lai et al. · 0 citations
Open access Sep 2026

MMEJ repair of breaks at TA repeats maintains ecDNA and cancer fitness

Extrachromosomal DNA (ecDNA) comprises megabase-sized circular DNA elements that frequently carry oncogene amplifications, driving aggressive tumour phenotypes, therapeutic resistance and poor clinical outcomes across many cancers1, 2, 3–4. Although ecDNA is thought to arise from canonical double-strand break repair, t...

David Billing, Monica Selvaraj, M. E. Kelley et al. · 1 citation
Review

The burden of abundance

Findings show that ecDNA is more than a carrier of amplified genes and its presence is associated with altered DNA-damage responses and specific cellular dependencies, supporting the idea that ecDNA itself imposes biological constraints on cancer cells and creates vulnerabilities that may be therapeutically exploitable...

M. Ilić · 0 citations
Review Open access Oct 2026

Extrachromosomal DNA: A New Therapeutic Frontier for Overcoming Cancer Drug Resistance

Extrachromosomal DNAs (ecDNAs) are acentric circular DNA molecules that frequently harbor amplified oncogenes and their regulatory elements. Although ecDNAs occur at low levels in normal cells, oncogenic ecDNAs are enriched in cancer, where they promote tumor evolution, intratumoral heterogeneity, and therapeutic resis...

Dooil Jeoung · 0 citations
Review Open access Jul 2026

Targeting Exportin-1 in Cancer: From Nuclear Export to Oncogenic Transcriptional Hubs

Maintaining cellular homeostasis requires precise coordination of molecular trafficking between the nucleus and the cytoplasm. Central to this process is the nucleocytoplasmic transport system, which governs the spatial distribution of proteins and RNA. Exportin-1 (XPO1), also known as chromosome region maintenance 1 (...

Seigi Oshima, K. Kanaoka, Wataru Saika et al. · 0 citations
Open access Oct 2026

An epigenetic program dictates MYC amplification dynamics that promote transient, extrachromosomal, and inherited genomic events.

MYC amplification is common and often extrachromosomal (ecDNA) in cancer. To define how MYC DNA copy gains arise from diploid genomes, we assessed whether epigenetic enzymes directly control focal MYC over-replication and amplification. We demonstrate that H3K4 methylation primes MYC for amplification by the H3K9/K36 t...

Benjamin Ferman, Chloe Azadegan, John Santoro et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.